Skip to main content
main-content
Top

01-18-2017 | Diabetic foot infection | Review | Article

Diabetic Foot Infections: an Update in Diagnosis and Management

Journal: Current Diabetes Reports

Authors: Pinelopi Grigoropoulou, Ioanna Eleftheriadou, Edward B. Jude, Nikolaos Tentolouris

Publisher: Springer US

share
SHARE

Abstract

Foot infections are a common problem in patients with diabetes and a risk factor for limb amputation. They occur as a result of skin ulceration, which facilitates penetration of pathogens to deeper tissues. The diagnosis of infection is clinical. Aerobic gram-positive cocci are the most common pathogens. Ulcers which are chronic, preceded by administration of antibiotics and hospitalization or complicated by severe infection are polymicrobial. Antibiotic therapy is initially empiric based on the severity of the infection. Definitive therapy is modified according to the results of the microbiological culture and the response to empiric treatment. The optimal duration of antibiotic therapy ranges from 1–2 weeks for mild infections to 2–4 weeks and even longer for severe infections and osteomyelitis. Surgical consultation should be sought for infections complicated with abscesses, necrotizing fasciitis or osteomyelitis. With appropriate care, infection resolves in about 80–90% of non-limb threatening and in about 60% of severe infections.
Literature
1.
Lipsky BA, Berendt AR, Cornia PB, et al. 2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2012;54:e132–73. CrossRefPubMed
2.
Lavery LA, Armstrong DG, Wunderlich RP, et al. Risk factors for foot infections in individuals with diabetes. Diabetes Care. 2006;29:1288–93. CrossRefPubMed
3.
Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, et al. The global burden of diabetic foot disease. Lancet. 2005;366:1719–24. CrossRefPubMed
4.
Pecoraro RE, Reiber GE, Burgess EM. Pathways to diabetic limb amputation. Basis for prevention. Diabetes Care. 1990;13:513–21. CrossRefPubMed
5.
Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA. 2005;293:217–28. CrossRefPubMed
6.
Prompers L, Huijberts M, Apelqvist J, et al. High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study. Diabetologia. 2007;50:18–25. CrossRefPubMed
7.
Centers for Disease Control and Prevention. Diabetes Public Health Resource. Age-Adjusted Hospital Discharge Rates for Peripheral Arterial Disease (PAD), Ulcer/Inflammation/Infection (ULCER), or Neuropathy as First-Listed Diagnosis per 1,000 Diabetic Population, United States, 1988–2007. http://​www.​cdc.​gov/​diabetes/​statistics/​hosplea/​diabetes_​complications/​fig2_​pop.​htm. Accessed 21 Sept 2016.
8.
• Peters EJ, Lipsky BA. Diagnosis and management of infection in the diabetic foot. Med Clin North Am. 2013;97:911–46. This is an interesting review that provides basic knowledge how to diagnose DFI.
9.
Lavery LA, Armstrong DG, Quebedeaux TL, et al. Puncture wounds: normal laboratory values in the face of severe infection in diabetics and non-diabetics. Am J Med. 1996;101:521–5. CrossRefPubMed
10.
Peters EJ, Lavery LA, Armstrong DG. Diabetic lower extremity infection: influence of physical, psychological, and social factors. J Diabetes Complicat. 2005;19:107–12. CrossRefPubMed
11.
Lavery LA, Armstrong DG, Murdoch DP, et al. Validation of the Infectious Diseases Society of America's diabetic foot infection classification system. Clin Infect Dis. 2007;44:562–5. CrossRefPubMed
12.
Armstrong DG, Lipsky BA. Diabetic foot infections: stepwise medical and surgical management. Int Wound J. 2004;1:123–32. CrossRefPubMed
13.
Consensus Development Conference on Diabetic Foot Wound Care: 7–8 April 1999, Boston, Massachusetts. American Diabetes Association. Diabetes Care. 1999; 22: 1354–1360.
14.
Boulton AJ, Armstrong DG, Albert SF, et al. Comprehensive foot examination and risk assessment: a report of the task force of the foot care interest group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists. Diabetes Care. 2008;31:1679–85. CrossRefPubMedPubMedCentral
15.
Sapico FL, Canawati HN, Witte JL, et al. Quantitative aerobic and anaerobic bacteriology of infected diabetic feet. J Clin Microbiol. 1980;12:413–20. PubMedPubMedCentral
16.
Bonham PA. Swab cultures for diagnosing wound infections: a literature review and clinical guideline. J Wound Ostomy Continence Nurs. 2009;36:389–95. CrossRefPubMed
17.
Leichter SB, Allweiss P, Harley J, et al. Clinical characteristics of diabetic patients with serious pedal infections. Metab Clin Exp. 1988;37:22–4. CrossRefPubMed
18.
Lipsky BA, Berendt AR, Deery HG, et al. Diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2004;39:885–910. CrossRefPubMed
19.
Game FL. Osteomyelitis in the diabetic foot: diagnosis and management. Med Clin North Am. 2013;97:947–56. CrossRefPubMed
20.
Armstrong DG, Lavery LA, Sariaya M, et al. Leukocytosis is a poor indicator of acute osteomyelitis of the foot in diabetes mellitus. J Foot Ankle Surg. 1996;35:280–3. CrossRefPubMed
21.
Butalia S, Palda VA, Sargeant RJ, et al. Does this patient with diabetes have osteomyelitis of the lower extremity? JAMA. 2008;299:806–13. CrossRefPubMed
22.
Dinh T, Snyder G, Veves A. Current techniques to detect foot infection in the diabetic patient. Int J Low Extrem Wounds. 2010;9:24–30. CrossRefPubMed
23.
Lavery LA, Walker SC, Harkless LB, et al. Infected puncture wounds in diabetic and nondiabetic adults. Diabetes Care. 1995;18:1588–91. CrossRefPubMed
24.
Sapico FL, Witte JL, Canawati HN, et al. The infected foot of the diabetic patient: quantitative microbiology and analysis of clinical features. Rev Infect Dis. 1984;6 Suppl 1:S171–6. CrossRefPubMed
25.
Armstrong DG, Liswood PJ, Todd WF. 1995 William J. Stickel bronze award. Prevalence of mixed infections in the diabetic pedal wound. A retrospective review of 112 infections. J Am Podiatr Med Assoc. 1995;85:533–7. CrossRefPubMed
26.
Tentolouris N, Jude EB, Smirnof I, et al. Methicillin-resistant Staphylococcus aureus: an increasing problem in a diabetic foot clinic. Diabet Med. 1999;16:767–71. CrossRefPubMed
27.
Ge Y, MacDonald D, Hait H, et al. Microbiological profile of infected diabetic foot ulcers. Diabet Med. 2002;19:1032–4. CrossRefPubMed
28.
Uckay I, Gariani K, Pataky Z, et al. Diabetic foot infections: state-of-the-art. Diabetes Obes Metab. 2014;16:305–16. CrossRefPubMed
29.
Uckay I, Aragon-Sanchez J, Lew D, et al. Diabetic foot infections: what have we learned in the last 30 years? Int J Infect Dis. 2015;40:81–91. CrossRefPubMed
30.
Eleftheriadou I, Tentolouris N, Argiana V, et al. Methicillin-resistant Staphylococcus aureus in diabetic foot infections. Drugs. 2010;70:1785–97. CrossRefPubMed
31.
Hartemann-Heurtier A, Robert J, Jacqueminet S, et al. Diabetic foot ulcer and multidrug-resistant organisms: risk factors and impact. Diabet Med. 2004;21:710–5. CrossRefPubMed
32.
Lavery LA, Peters EJ, Armstrong DG, et al. Risk factors for developing osteomyelitis in patients with diabetic foot wounds. Diabetes Res Clin Pract. 2009;83:347–52. CrossRefPubMed
33.
Berendt AR, Peters EJ, Bakker K, et al. Diabetic foot osteomyelitis: a progress report on diagnosis and a systematic review of treatment. Diabetes Metab Res Rev. 2008;24 Suppl 1:S145–61. CrossRefPubMed
34.
Lesens O, Desbiez F, Vidal M, et al. Culture of per-wound bone specimens: a simplified approach for the medical management of diabetic foot osteomyelitis. Clin Microbiol Infect. 2011;17:285–91. CrossRefPubMed
35.
Kaleta JL, Fleischli JW, Reilly CH. The diagnosis of osteomyelitis in diabetes using erythrocyte sedimentation rate: a pilot study. J Am Podiatr Med Assoc. 2001;91:445–50. CrossRefPubMed
36.
Grayson ML, Gibbons GW, Balogh K, et al. Probing to bone in infected pedal ulcers. A clinical sign of underlying osteomyelitis in diabetic patients. JAMA. 1995;273:721–3. CrossRefPubMed
37.
• Lipsky BA, Aragon-Sanchez J, Diggle M, et al. IWGDF guidance on the diagnosis and management of foot infections in persons with diabetes. Diabetes Metab Res Rev. 2016;32 Suppl 1:45–74. This is the most recent consensus document by the IWGDF for the diagnosis and treatment of DFI.
38.
Lipsky BA, Peters EJ, Senneville E, et al. Expert opinion on the management of infections in the diabetic foot. Diabetes Metab Res Rev. 2012;28 Suppl 1:163–78. CrossRefPubMed
39.
Sella EJ. Current concepts review: diagnostic imaging of the diabetic foot. Foot Ankle Int. 2009;30:568–76. CrossRefPubMed
40.
Yuh WT, Corson JD, Baraniewski HM, et al. Osteomyelitis of the foot in diabetic patients: evaluation with plain film, 99mTc-MDP bone scintigraphy, and MR imaging. AJR. 1989;152:795–800. CrossRefPubMed
41.
Lipman BT, Collier BD, Carrera GF, et al. Detection of osteomyelitis in the neuropathic foot: nuclear medicine, MRI and conventional radiography. Clin Nucl Med. 1998;23:77–82. CrossRefPubMed
42.
Capriotti G, Chianelli M, Signore A. Nuclear medicine imaging of diabetic foot infection: results of meta-analysis. Nucl Med Commun. 2006;27:757–64. CrossRefPubMed
43.
Ertugrul BM, Lipsky BA, Savk O. Osteomyelitis or Charcot neuro-osteoarthropathy? Differentiating these disorders in diabetic patients with a foot problem. Diabetic foot & ankle. 2013; 4:
44.
Kapoor A, Page S, Lavalley M, et al. Magnetic resonance imaging for diagnosing foot osteomyelitis: a meta-analysis. Arch Intern Med. 2007;167:125–32. CrossRefPubMed
45.
Newman LG, Waller J, Palestro CJ, et al. Leukocyte scanning with 111In is superior to magnetic resonance imaging in diagnosis of clinically unsuspected osteomyelitis in diabetic foot ulcers. Diabetes Care. 1992;15:1527–30. CrossRefPubMed
46.
Poirier JY, Garin E, Derrien C, et al. Diagnosis of osteomyelitis in the diabetic foot with a 99mTc-HMPAO leucocyte scintigraphy combined with a 99mTc-MDP bone scintigraphy. Diabetes Metab. 2002;28:485–90. PubMed
47.
Basu S, Chryssikos T, Houseni M, et al. Potential role of FDG PET in the setting of diabetic neuro-osteoarthropathy: can it differentiate uncomplicated Charcot's neuroarthropathy from osteomyelitis and soft-tissue infection? Nucl Med Commun. 2007;28:465–72. CrossRefPubMed
48.
Lio PA, Kaye ET. Topical antibacterial agents. Infect Dis Clin N Am. 2009;23:945–63. ix CrossRef
49.
Vermeulen H, van Hattem JM, Storm-Versloot MN, et al. Topical silver for treating infected wounds. Cochrane Database Syst Rev. 2007; CD005486.
50.
Lipsky BA, Holroyd KJ, Zasloff M. Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double-blinded, multicenter trial of pexiganan cream. Clin Infect Dis. 2008;47:1537–45. CrossRefPubMed
51.
Lipsky BA. Evidence-based antibiotic therapy of diabetic foot infections. FEMS Immunol Med Microbiol. 1999;26:267–76. CrossRefPubMed
52.
Peters EJ, Lipsky BA, Berendt AR, et al. A systematic review of the effectiveness of interventions in the management of infection in the diabetic foot. Diabetes Metab Res Rev. 2012;28(Suppl 1):142–62. CrossRefPubMed
53.
Jude EB, Unsworth PF. Optimal treatment of infected diabetic foot ulcers. Drugs Aging. 2004;21:833–50. CrossRefPubMed
54.
Cruciani M, Lipsky BA, Mengoli C, et al. Granulocyte-colony stimulating factors as adjunctive therapy for diabetic foot infections. Cochrane Database Syst Rev. 2009; CD006810.
55.
Kranke P, Bennett MH, Martyn-St James M, et al. Hyperbaric oxygen therapy for chronic wounds. Cochrane Database Syst Rev. 2012;4:CD004123.
56.
Lazzarini L, Lipsky BA, Mader JT. Antibiotic treatment of osteomyelitis: what have we learned from 30 years of clinical trials? Int J Infect Dis. 2005;9:127–38. CrossRefPubMed
57.
Aragon-Sanchez J, Quintana-Marrero Y, Lazaro-Martinez JL, et al. Necrotizing soft-tissue infections in the feet of patients with diabetes: outcome of surgical treatment and factors associated with limb loss and mortality. Int J Low Extrem Wounds. 2009;8:141–6. CrossRefPubMed

New additions to the Adis Journal Club

A selection of topical peer-reviewed articles from the Adis journals, curated by the editors.

ADA 2022 coverage

Access the latest news and expert insight from the ADA 82nd Scientific Sessions